Real-world evidence of multi-systemic therapy for hepatocellular carcinoma

被引：0
|
作者：
Aikata, Hiroshi [1 ]
Yamauchi, Masami [1 ]
Ono, Atsushi
Miki, Daiki
Tsuge, Masataka
Chayama, Kazuaki
机构：
[1] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SST5-4
引用
收藏
页码：1066 / 1066
页数：1
相关论文
共 50 条
  • [41] A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma
    Li, Qingqing
    Su, Tong
    Zhang, Xu
    Pan, Yanfeng
    Ma, Shengli
    Zhang, Lu
    Zhang, Xianqiang
    Gao, Xiaojuan
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3037 - 3046
  • [42] A real-world study of Chinese hepatocellular carcinoma patients treated with TACE
    Hu, H-F
    Sang, Y-F
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3091 - 3099
  • [43] Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data
    Shimose, Shigeo
    Sugimoto, Rie
    Hiraoka, Atsushi
    Tanaka, Masatoshi
    Iwamoto, Hideki
    Tanaka, Yuki
    Tada, Fujimasa
    Ohama, Hideko
    Niizeki, Takashi
    Shirono, Tomotake
    Moriyama, Etsuko
    Noda, Yu
    Kamachi, Naoki
    Nakano, Masahito
    Kuromatsu, Ryoko
    Koga, Hironori
    Kawaguchi, Takumi
    [J]. HEPATOLOGY RESEARCH, 2023, 53 (02) : 116 - 126
  • [44] Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03)
  • [45] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Chen, Jinbin
    Xiong, Peiyao
    Nie, Man
    Pan, Yangxun
    Wang, Juncheng
    Hu, Dandan
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Xu, Li
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2491 - 2500
  • [46] Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study
    Tu, Xinyue
    Yang, Jing
    Zheng, Yingbin
    Liang, Chen
    Tao, Qiang
    Tang, Xiang
    Liu, Zonghao
    Jiang, Lingmin
    He, Zhaoqian
    Xie, Feihu
    Zheng, Yun
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [47] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Jinbin Chen
    Peiyao Xiong
    Man Nie
    Yangxun Pan
    Juncheng Wang
    Dandan Hu
    Zhongguo Zhou
    Yaojun Zhang
    Minshan Chen
    Li Xu
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2491 - 2500
  • [48] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
    Obi, Shuntaro
    Sato, Takahisa
    Sato, Shinpei
    Kanda, Miho
    Tokudome, Yuta
    Kojima, Yuichiro
    Suzuki, Yoji
    Hosoda, Kenji
    Kawai, Toshihiro
    Kondo, Yuji
    Isomura, Yoshihiro
    Ohyama, Hiroshi
    Nakagomi, Keiko
    Ashizawa, Hiroshi
    Miura, Yuko
    Amano, Hiroyuki
    Mochizuki, Hitoshi
    Omata, Masao
    [J]. HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 199 - 204
  • [49] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
    Shuntaro Obi
    Takahisa Sato
    Shinpei Sato
    Miho Kanda
    Yuta Tokudome
    Yuichiro Kojima
    Yoji Suzuki
    Kenji Hosoda
    Toshihiro Kawai
    Yuji Kondo
    Yoshihiro Isomura
    Hiroshi Ohyama
    Keiko Nakagomi
    Hiroshi Ashizawa
    Yuko Miura
    Hiroyuki Amano
    Hitoshi Mochizuki
    Masao Omata
    [J]. Hepatology International, 2019, 13 : 199 - 204
  • [50] Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data.
    Bezalel, Nomi
    Davidov, Yana
    Likhter, Mariya
    Ezra, Oranit Cohen
    Inbar, Yael
    Halpern, Naama
    Ben Boursi
    Beller, Tamar
    Pery, Ron
    Shmueli, Einat S.
    Nachmany, Ido
    Ben Ari, Ziv
    Margalit, Ofer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345